Glendon E. French III - 01 Sep 2026 Form 4 Insider Report for Pulmonx Corp (LUNG)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Sep 2026, 18:23:50 UTC
Prior SEC filing
03 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ David Aaron Lehman, Attorney-in-Fact

Key filing fact

Glendon E. French III filed Form 4 for Pulmonx Corp (LUNG) on 03 Sep 2026.

Key facts

  • This page summarizes Glendon E. French III's Form 4 filing for Pulmonx Corp (LUNG).
  • 2 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 03 Sep 2026, 18:23.

Change

  • Previous filing in this sequence was filed on 03 Jun 2026.
  • Current net transaction value: -$94,653.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001805624 Primary reporting owner

French Glendon E. III

Relationship
President and CEO, Director
Address
C/O PULMONX CORPORATION, 700 CHESAPEAKE DRIVE, REDWOOD CITY
Signature
/s/ David Aaron Lehman, Attorney-in-Fact
Signature date
03 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LUNG transaction

Common Stock

Sale

Transaction value
$9,261
Shares
-4,098
Change %
-0.35%
Price
$2.26
Shares after
1,175,720
Date
01 Sep 2026
Ownership
Direct
Footnotes
F1, F2
LUNG transaction

Common Stock

Sale

Transaction value
$85,392
Shares
-37,784
Change %
-3.2%
Price
$2.26
Shares after
1,137,936
Date
01 Sep 2026
Ownership
Direct
Footnotes
F3
LUNG holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
918,198
Date
01 Sep 2026
Ownership
By trust
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 1, 2023.

Footnote F2

Includes 1,656 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on August 14, 2026.

Footnote F3

These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on December 1, 2025.

Footnote F4

The shares are held by the Glendon E French & Gayle French Trustees French Family Rev Trust UA DTD 08/29/2012, of which the reporting person and his spouse are trustees and beneficiaries.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .